Rewiring neurological care: The role of AI and graphene in BCI therapeutics

The convergence of semiconductor innovation, advanced materials, and artificial intelligence is unlocking a new frontier in brain related medicine. In this session, INBRAIN Neuroelectronics will share how its graphene-based brain-computer interface (BCI) platform—built using semiconductor-grade microfabrication—enables a new category of BCI therapeutics (BCI-Tx) for neurological disorders.

We will explore how graphene’s ultra-thin, high-resolution properties enable unprecedented neural precision, while AI copilots adaptively tune therapies to individual patients in real-time. This integrated BCI-Tx approach is not only restoring lost functions—it is reshaping the therapeutic landscape by making the brain both the source and driver of its own treatment

Unlike traditional neurostimulation systems, INBRAIN’s technology is a scalable, semiconductor-based platform, positioning it to power the next generation of implantable therapeutics—not only for Parkinson’s Disease, but across a spectrum of chronic brain conditions.

Join us to explore how semiconductor neurotechnology is rewiring the future of neurological care